While HR teams spent the past five years championing virtual doctor visits and online therapy sessions, the 93 million American adults the CDC identifies as at high risk for vision loss kept driving to strip mall eye clinics, losing two-plus hours to do it, and skipping appointments at staggering rates.
Most benefits leaders I talk to don't think twice about this. Vision coverage is cheap. It keeps employees happy. What's the big deal?
That $18-per-month vision plan is an early warning system for your most expensive medical claims, and almost nobody's paying attention.
Your Vision Plan Knows Things Your Medical Plan Doesn't
Skipping an annual eye exam means missing early warnings for conditions that an optometrist can spot by looking at the back of your eye:
- Diabetic retinopathy, a sign of microvascular damage that independently predicts cardiovascular events
- Hypertensive retinopathy signaling stroke risk before symptoms appear
- Early indicators of Alzheimer's, multiple sclerosis, and certain cancers
- Glaucoma patterns associated with cognitive decline
A routine eye exam can identify people heading toward six-figure medical claims, the kind that blow up your renewal rates and send your CFO into crisis mode.
Completion looks fine in the aggregate, but the gap is hiding in the people who need exams most. A CDC analysis found that about 4 in 10 US adults at high risk for vision loss did not get an eye exam in the prior year. Ask the ones who skip, and the answer is usually the same: "I can't take that much time off work."
That response should bother you more than it does.
The Real Cost Nobody Calculates
Walk through what a traditional eye exam requires from your employees:
- Drive to the shop (20 minutes)
- Wait (15 minutes)
- Exam and dilation (45 minutes)
- Recover enough to drive (30 minutes)
- Drive back (20 minutes)
- Get back into work mode (20 minutes)
Total time: 2.5 hours, minimum.
For an employee earning $60,000 annually, that's about $75 in lost productivity per eye exam. Multiply that across a few hundred employees, factor in the four in ten high-risk adults who skip entirely, and you're looking at a system that's broken by design.
Meanwhile, FDA-cleared technology that removes most of this friction has been on the market for years. An online visual acuity test cleared by the FDA in 2022 renews glasses and contact lens prescriptions from a kitchen table in about 15 minutes.
Adoption in employer benefits remains rare.
Why Your Vision Plan Doesn't Want You to Know About This
Most vision plans make more money when employees buy glasses than when they prevent blindness.
Look at who controls the market. VSP and EyeMed together handle roughly 85% of employer vision benefits, and Davis Vision and smaller carriers split the rest. Their business model depends on a carefully constructed funnel:
- Get employees into retail optical locations
- Generate prescriptions during exams
- Sell glasses at retail prices that far exceed their production cost
Eye exams are often loss leaders, the thing that gets people through the door so they'll buy frames priced in the hundreds that cost a small fraction of that to produce. When virtual exams let employees skip the retail location entirely, that whole economic model falls apart.
That's why virtual options get buried in plan documents, priced higher than in-person visits, or excluded altogether. The system is working exactly as designed, but not in your favor.
The Three Walls Blocking Innovation
The Medical-Vision Divide: In most companies, different people buy medical coverage and vision coverage. They never talk to each other. Your medical plan team chasing better diabetes outcomes has no idea the vision plan could provide exactly the screening data they need. Your vision plan buyer focused on keeping premiums flat doesn't realize they're sitting on medical intelligence worth millions.
The Data Black Hole: Ask your vision plan administrator what happens to the clinical information from your employees' eye exams. I have asked this question dozens of times. The data sits in proprietary systems that don't communicate with medical plans, pharmacy benefits managers, or wellness platforms. Your medical plan never learns about a diabetic retinopathy diagnosis. A hypertension indicator is gone. The employee who needs glaucoma monitoring has no follow-up system waiting.
The Retail Trap: Traditional eye exams exist primarily to generate prescriptions for retail optical sales. This is the part nobody wants to say out loud, but it explains why innovation moves at a crawl. Virtual exams threaten decades of retail partnerships and revenue streams. The resistance is about protecting margin, not clinical quality.
What FDA-Cleared Technology Can Do Right Now
This technology is available today:
Smartphone-Based Refraction Testing: Apps can measure nearsightedness, farsightedness, and astigmatism, then generate valid prescriptions for glasses and contacts. The first FDA-cleared online visual acuity test renews prescriptions in about 10 minutes, though its clearance covers adults ages 22 to 40 and applies to prescription renewal, not disease screening.
Portable Retinal Imaging: Tablet-connected cameras capture high-resolution photographs of the retina. They detect diabetic retinopathy at medical-grade accuracy and flag glaucoma, macular degeneration, and hypertensive changes. The devices cost a fraction of traditional tabletop systems.
AI-Powered Analysis: FDA-cleared algorithms analyze retinal images, triage high-risk cases, generate referral urgency scores, and track disease progression over time. The AI doesn't replace eye doctors. It makes them more efficient by handling routine screenings and flagging urgent cases.
The clinical results are not a downgraded telehealth substitute. For routine prescription renewal and diabetic retinal screening, they compare favorably with in-office testing.
Where Virtual Exams Fall Short
Virtual exams are not a wholesale replacement for a comprehensive dilated exam. The first FDA-cleared online test is approved only for renewing glasses and contact lens prescriptions in adults ages 22 to 40, and the FDA has said it is not a substitute for a broader eye health exam or for screening other conditions. Children, people with strong or irregular prescriptions, and anyone with diabetes, glaucoma, or a history of eye disease still need an in-person dilated exam. The diabetic retinal screening that catches retinopathy early relies on a retinal camera or a dilated fundus exam, not a refraction app. That difference matters, because it determines where the savings come from. A virtual program earns its keep when it pairs convenient refraction with structured retinal imaging for the employees at highest risk and routes everyone else to in-person care when findings warrant it. Virtual care is a front door. For the people who need it, the dilated exam remains the standard.
Let Me Show You the Math
Take 500 employees and look at what the current system delivers:
Traditional Vision Benefit:
- Annual premium: $108,000 ($18 per employee per month)
- What it buys: access to a retail network built to sell glasses
- What it doesn't do: route clinical findings to your medical plan
- Result: a diabetic employee whose retinopathy goes undetected until it becomes a late-stage, expensive complication
Now look at what changes with integrated virtual screening:
Virtual Eye Exam Program:
- Design goal: complete the screening, not sell a frame
- What it adds: a reward for completion and a direct line from findings to medical decision-making
- Result: retinopathy, hypertension, and glaucoma caught earlier, when treatment costs less
The exact savings depend on your population and your current utilization, but the direction is not in dispute. Earlier detection costs less than late-stage treatment, and the complications averted land on the medical plan's claims, not the vision plan's.
Add in early detection of hypertension, glaucoma, and other conditions that show up in eye exams, and the ROI becomes impossible to ignore.
But this only works if three things happen:
- Employees complete the exams (requires removing friction and adding real incentives)
- Data flows into medical decision-making (requires platform integration)
- Economics align with health outcomes (requires moving away from retail-dependent models)
Traditional vision plans can't deliver any of these because their business model depends on the dysfunction continuing.
How WellthCare™ Built It Differently
We looked at this and realized something: you can't fix vision benefits by tweaking them. You have to redesign how preventive care works from scratch.
That's why WellthCare doesn't treat vision screening as a retail transaction. We treat it as preventive surveillance that prevents catastrophic claims, and we reward employees immediately for completing it.
How It Works
Immediate rewards: Complete a virtual eye exam through WellthCare and you earn instant reward dollars to spend at the WellthCare Store™ on 3,000+ health-related products. Real, spendable dollars, not points. You also build retirement savings automatically. If the screening finds something that needs follow-up, that care costs you zero dollars out of pocket.
The math is straightforward. Employees complete it because the rewards are immediate. Employers save money because problems get caught early. Nobody has to be coerced or reminded or incentivized with t-shirts and raffles.
Integrated intelligence: Virtual eye exams generate structured digital data that traditional exams don't capture effectively. WellthCare's Health-to-Wealth™ platform uses this data to power its Readiness Index™, tracking every preventive action, generating clinician-reviewed plans of care, and funding Store rewards. Employer-committed savings fund automatic retirement contributions. The platform analyzes retinal images longitudinally, tracks visual field results for signs of cognitive decline, and flags glaucoma risk from intraocular pressure trends before vision loss occurs.
This data doesn't disappear into a vision plan silo. It feeds our Readiness Index, which identifies which employees need immediate medical referrals, who's at risk for high-cost chronic conditions, where preventive interventions will generate the highest return, and when Medicare-eligible employees should transition off the employer plan.
No friction: Virtual eye exams through WellthCare take 15 to 20 minutes total. Employees can complete them during work hours, on lunch breaks, or from home. There is no driving, no waiting room, and no dilation recovery time. Results arrive within 48 hours, and prescriptions are valid anywhere employees want to buy glasses.
Remove friction and add immediate financial rewards, and utilization climbs sharply. Early pilots pointed in this direction.
Five Questions You Should Ask Your Current Vision Plan
Next time you're reviewing vision benefits, try asking these questions and watch what happens:
- "What percentage of our diabetic employees completed retinal screening last year, and how many cases of retinopathy did you detect?" Most plans can't answer because they don't track medical diagnoses across their systems.
- "Can you prove that higher utilization reduces our medical claims?" They can't, because their revenue model depends on retail sales, not prevention outcomes.
- "Can you integrate eye exam data into our wellness platform, pharmacy benefits manager, and Medicare transition planning?" The answer will be no. They operate in disconnected silos by design.
- "If virtual eye exams cost less and work for most routine needs, why aren't they the default option?" Because it would destroy their retail partnerships.
- "Can our medical plan access clinical data from eye exams for care coordination?" It disappears into proprietary systems that don't communicate with anyone else.
These questions reveal the misalignment in traditional vision benefits. The plan administrators and the employers have different definitions of success.
The Compliance Issues Nobody's Talking About Yet
Virtual eye exams aren't just better economics. They may soon be legally required for certain populations.
ADA Reasonable Accommodation: Remote workers are increasingly requesting vision care accommodations citing ADA protections. If an in-person exam requires two or more hours away from work and a virtual alternative with equivalent accuracy exists, an employer may have an obligation to offer it.
OSHA Vision Safety Requirements: OSHA does not require routine vision screening for most employees. Its standards require eye and face protection from workplace hazards, and it has no general color vision requirement. A few regulated roles, crane operators among them, carry their own acuity standards. Virtual exams with documented medical oversight can satisfy those checks at a fraction of the cost while generating compliance documentation.
Medicare Advantage Star Ratings: CMS Star Ratings already include a diabetes care eye exam measure. For employers with Medicare-eligible employees, closing that gap creates direct value in ways most benefits teams haven't considered yet.
Why Standalone Solutions Keep Failing
Several companies have launched virtual eye exam platforms over the past few years. Most haven't gained meaningful traction in employer benefits.
Standalone Virtual Eye Exam Companies: They operate on a one-time transaction model with no connection to medical data, no behavioral incentives driving completion, and no integration with employer wellness programs. Their business model still depends on selling glasses. They moved the transaction online.
Traditional Vision Plans Adding Telehealth: They bolt on virtual options while protecting their retail channels. They financially penalize virtual exams in the benefit design. They don't share data with medical plans. They have no integration with pharmacy or Medicare. The incentive misalignment remains unchanged.
WellthCare's Integrated Approach: Virtual eye exams are part of a broader Health-to-Wealth system. Employees earn reward dollars and automatic retirement contributions immediately for completion. Data feeds medical intelligence and utilization modeling. The system identifies pharmacy savings opportunities and enables Medicare transition planning. It reduces total cost of care across medical, pharmacy, and vision simultaneously. Everyone wins when employees are healthier. That is how the economics work, not a marketing line.
The moat is the incentive structure, not the technology. Lots of companies have good tech. What they lack is a structure that makes adoption inevitable instead of optional.
What Implementation Looks Like
If you're thinking this makes sense but wondering about the practical steps, the rollout usually looks like this:
Phase 1: High-Risk Pilot (Months 1–3)
Start with employees who have diagnosed diabetes, hypertension, or family history of glaucoma or macular degeneration. Offer virtual eye exams with instant rewards. Track completion rates, clinical findings, and downstream medical referrals.
Expected return: the early savings come from avoided complications in your highest-risk employees.
Phase 2: Full Population Rollout (Months 4–6)
Expand to all employees during annual enrollment. Position it as "healthcare that pays you back" rather than another wellness program. Integrate with existing telemedicine platforms where possible.
Expected return: savings build as utilization scales and early detections add up.
Phase 3: Total Cost of Care Integration (Months 7–12)
Use eye exam data to refine pharmacy utilization modeling. Identify Medicare-eligible employees who should transition off the employer plan. Feed data into benefits optimization.
Expected return: the largest savings come from combining medical, pharmacy, and Medicare levers.
Phase 4: Continuous Optimization
Annual retinal imaging for all diabetics becomes standard protocol, along with biennial screening for everyone over 40, immediate follow-up care coordination for high-risk findings, and longitudinal AI analysis to detect early disease progression.
This is where the patent-pending technology provides permanent competitive advantage. The system gets smarter over time as it accumulates more data about your specific population.
Where This Technology Is Heading
The next generation of vision technology moves beyond once-a-year prescription checks. It becomes continuous health surveillance:
- Smartphone cameras that detect pupil response changes indicating neurological issues
- Wearable devices that monitor intraocular pressure throughout the day for glaucoma prediction
- AI analysis of regular photos detecting jaundice, anemia, and orbital tumors
- Contact lenses with embedded sensors measuring glucose levels in tears for non-invasive diabetes monitoring
This isn't science fiction. The technology exists in labs right now. Commercial availability is 3–5 years out, maybe sooner.
The company that controls the data infrastructure and behavioral incentive system to deploy this at scale will win the entire benefits industry. That's why we're building the Health-to-Wealth™ Operating System now, not after competitors figure out what we already know.
What This Means for Your Organization
For any organization serious about these goals, telemedicine for eye exams is a strategic requirement:
- Preventing catastrophic medical claims before they happen
- Increasing preventive care utilization beyond the dismal current rates
- Generating actionable health intelligence that improves outcomes
- Supporting remote and hybrid workforce needs effectively
- Complying with emerging ADA and OSHA requirements
- Managing total cost of care instead of shifting it around
But it only works when employees complete the exams, when data flows into medical decision-making, and when economics align with health outcomes rather than retail sales.
Traditional vision plans can't deliver this because their business model depends on the current dysfunction continuing indefinitely.
WellthCare can, because we designed the entire system around the principle that better health should build real wealth.
The eye exam is proof of concept, not the product. It demonstrates that employees will enthusiastically engage with preventive care when you remove friction and add immediate financial rewards.
It generates the clinical intelligence that powers smarter benefits decisions. It identifies the opportunities that save employers millions in avoidable claims. And it proves the model works before asking anyone to abandon their existing health plan.
Once decision-makers see it working, once employees are measurably healthier, building real wealth, and more engaged, the move to the broader system becomes mathematically inevitable rather than a leap of faith.
That is system design that aligns everyone's incentives for the first time.